Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably amon...
Publications
2 shownA Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Both MAb114 and REGN-EB3 were superior to ZMapp in reducing mortality from EVD. Scientifically and ethically sound clinical research can be conducted during disease outbreaks an...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 3,420
- Institution
- Baylor College of Medicine
External Links
Identifiers
- ORCID
- 0000-0002-3992-5524
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.